Clinical Trial Update: Metformin With Neoadjuvant Chemoradiation to Improve Pathologic Responses in Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating metformin with neoadjuvant chemoradiation to improve pathologic responses in rectal cancer; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Rectal Neoplasm Carcinoma in Situ Adenocarcinoma | Phase 2 | Status: COMPLETED